Hörby, Sweden

Lena Wester Rosenlöf

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: A1m Pharma Ab, Guard Therapeutics International Ab. Active years: 2019-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lena Wester Rosenlöf. Retrieved from https://idiyas.com/inventor/lena-wester-rosenlöf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lena Wester Rosenlöf: Innovator in Medical Proteins

Introduction

Lena Wester Rosenlöf is a prominent inventor based in Hörby, Sweden. She has made significant contributions to the field of medical proteins, particularly through her innovative patents. With a total of 2 patents, her work focuses on the therapeutic applications of alpha-1-microglobulin derived proteins.

Latest Patents

Lena's latest patents include "Alpha-1-microglobulin derived proteins and their use," which relates to an alpha-1-microglobulin derived protein for medical use. Another notable patent is "Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases," which addresses the use of alpha-1-microglobulin in treating diseases related to mitochondrial dysfunction.

Career Highlights

Throughout her career, Lena has worked with notable companies such as Guard Therapeutics International AB and A1M Pharma AB. Her expertise in medical proteins has positioned her as a key player in the biotechnology sector.

Collaborations

Lena has collaborated with esteemed colleagues, including Anneli Edström Hägerwall and Bo Åkerström, further enhancing her research and development efforts in the field.

Conclusion

Lena Wester Rosenlöf's innovative work in medical proteins showcases her dedication to advancing healthcare solutions. Her contributions through patents and collaborations highlight her impact on the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…